NPC1 and metastatic prostate carcinoma: The studies of Rodriguez-Bravo et al. [57] identified elevated levels of NPC proteins such as POM121, Nup188, Nup210, Nup85, Nup62, and Nup214 in metastatic prostate cancer, indicating that NPC dysregulation may drive aggressive cancer phenotypes [58,59].